NCT04368806 - A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis | Biotech Hunter

Enrollment

140

Participants

Timeline

Start Date

May 26, 2021

Primary Completion Date

December 30, 2026

Study Completion Date

December 31, 2026

Conditions

Osteoarthritis, Knee

Interventions

DRUG

JointStem

Autologous Adipose tissue derived Mesenchymal Stem Cells (AdMSC)

OTHER

Placebo Control

Normal Saline with autologous Serum

Trial Locations (9)

90403

RECRUITING

Source Healthcare, Santa Monica

91942

RECRUITING

BioSolutions Clinical Research Center, La Mesa

92020

RECRUITING

TriWest Research Associates, El Cajon

92660

RECRUITING

Newport Therapeutics, Newport Beach

94558

RECRUITING

Neurovations Research, Napa

Republic of, 42601

RECRUITING

Keimyung University Dongsan Hospital, Daegu

Republic of, 02447

RECRUITING

Kyung Hee University Medical Center, Seoul

Republic of, 05278

RECRUITING

Kyung Hee University Hospital At Gangdong, Seoul

Republic of, 07061

RECRUITING

Smg-Snu Boramae Medical Center, Seoul

All Listed Sponsors

lead

Nature Cell Co. Ltd.

INDUSTRY